These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1185 related articles for article (PubMed ID: 17133156)

  • 1. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
    Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
    Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta.
    Singleton RJ; Bruden D; Bulkow LR
    Pediatr Infect Dis J; 2007 Nov; 26(11 Suppl):S46-50. PubMed ID: 18090200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R; Dooley L; Bruden D; Raelson S; Butler JC
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.
    Stockman LJ; Curns AT; Anderson LJ; Fischer-Langley G
    Pediatr Infect Dis J; 2012 Jan; 31(1):5-9. PubMed ID: 21817948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
    Madhi SA; Kuwanda L; Cutland C; Klugman KP
    J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
    Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.
    Light M; Bauman J; Mavunda K; Malinoski F; Eggleston M
    Pediatr Infect Dis J; 2008 Jun; 27(6):512-8. PubMed ID: 18449062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus risk factors in late preterm infants.
    Lanari M; Silvestri M; Rossi GA
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():102-7. PubMed ID: 19925369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.
    Kaneko M; Watanabe J; Kuwahara M; Ueno E; Hida M; Kinoshita A; Sone T
    J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
    Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD
    Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.
    Fryzek JP; Martone WJ; Groothuis JR
    Adv Ther; 2011 Mar; 28(3):195-201. PubMed ID: 21327753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.
    Yorita KL; Holman RC; Steiner CA; Effler PV; Miyamura J; Forbes S; Anderson LJ; Balaraman V
    Pediatr Infect Dis J; 2007 Dec; 26(12):1081-8. PubMed ID: 18043442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes Registry.
    Frogel M; Nerwen C; Boron M; Cohen A; VanVeldhuisen P; Harrington M; Groothuis J;
    Pediatr Infect Dis J; 2008 Oct; 27(10):870-3. PubMed ID: 18776822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: potential for savings.
    Marchetti A; Lau H; Magar R; Wang L; Devercelli G
    Clin Ther; 1999 Apr; 21(4):752-66. PubMed ID: 10363740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
    Zachariah P; Ruttenber M; Simões EA
    J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.